A Phase 2 Study of the Fully Oral Combination of ASTX727 (Decitabine/Cedazuridine) Plus Venetoclax for Older and/or Unfit Patients with Acute Myeloid Leukemia

被引：4
|
作者：
Bazinet, Alexandre [1 ]
Garcia-Manero, Guillermo [2 ]
Short, Nicholas J. [1 ]
Valero, Yesid Alvarado [1 ]
Abuasab, Tareq [1 ]
Islam, Md Rabiul [2 ]
Montalbano, Kathryn [1 ]
Issa, Ghayas C. [1 ]
Maiti, Abhishek [1 ]
Yilmaz, Musa [1 ]
Jain, Nitin [1 ]
Masarova, Lucia [1 ]
Kornblau, Steven M. [1 ]
Jabbour, Elias [2 ]
Montalban-Bravo, Guillermo [2 ]
Pierce, Sherry [1 ]
DiNardo, Courtney D. [1 ]
Kadia, Tapan M. [1 ]
Daver, Naval [1 ]
Konopleva, Marina Y. [3 ,4 ]
Kantarjian, Hagop M. [5 ]
Ravandi, Farhad [2 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Montefiore Med Ctr, Dept Oncol, 111 E 210Th St, Bronx, NY 10467 USA
[4] Albert Einstein Coll Med, Bronx, NY 10467 USA
[5] Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-172658
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Trial in Progress: Venetoclax in Combination with ASTX727, an All-Oral Therapy for Chronic Myelomonocytic Leukemia and Other MDS/MPN with Excess Blasts (VICTORY MDS/MPN): A Randomized, Phase 2 Trial
    Shallis, Rory M.
    Blaha, Ondrej
    Halene, Stephanie
    Mendez, Lourdes
    Podoltsev, Nikolai A.
    Caldwell, Anne
    Bewersdorf, Jan Philipp
    Little, Richard F.
    Piekarz, Richard
    Patnaik, Mrinal M.
    Gore, Steven D.
    Zeidan, Amer M.
    BLOOD, 2023, 142
  • [32] PHASE 1 DOSE-ESCALATION STUDY OF ORAL ASTX727, A COMBINATION OF ORAL DECITABINE WITH A CYTIDINE DEAMINASE INHIBITOR (CDAI) E7727, IN SUBJECTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    Savona, M. R.
    Odenike, O.
    Amrein, P.
    Steensma, D.
    DeZern, A.
    Michaelis, L.
    Faderl, S.
    Oganesian, A.
    Lowder, J.
    Taverna, P.
    Azab, M.
    Garcia-Manero, G.
    HAEMATOLOGICA, 2016, 101 : 73 - 73
  • [33] A Phase II Study of the Combination of Decitabine, Venetoclax and Ponatinib in Patients with Chronic Myeloid Leukemia (CML) in Myeloid Blast Phase (MBP) or Philadelphia-Chromosome Positive (Ph plus ) Acute Myeloid Leukemia (AML)
    Senapati, Jayastu
    Ravandi, Farhad
    DiNardo, Courtney D.
    Issa, Ghayas C.
    Sasaki, Koji
    Konopleva, Marina
    Pemmaraju, Naveen
    Chien, Kelly S.
    Ohanian, Maro
    Jabbour, Elias
    Maiti, Abhishek
    Roy, Edith
    Delumpa, Ricardo
    Rivera, Juan
    Loiselle, Christopher
    Banks, Glenda
    Kantarjian, Hagop
    Short, Nicholas
    BLOOD, 2022, 140 : 3880 - 3882
  • [34] A Phase I Study of Uproleselan Combined with Azacitidine and Venetoclax for the Treatment of Older or Unfit Patients with Treatment Naive Acute Myeloid Leukemia
    Jonas, Brian A.
    Welborn, Jeanna L.
    Esteghamat, Naseem S.
    Hoeg, Rasmus T.
    Rosenberg, Aaron S.
    Molnar, Laura
    Dang-Chu, Ashley Linh
    Stewart, Susan L.
    Tuscano, Joseph M.
    BLOOD, 2022, 140 : 6213 - 6214
  • [35] Randomized Phase 1-2 Study to Assess Safety and Efficacy of Low-Dose (LD) Oral Decitabine/ Cedazuridine (ASTX727) in Lower-Risk Myelodysplastic Syndromes (LR-MDS) Patients: Interim Safety Analysis
    Garcia-Manero, Guillermo
    Bachiashvili, Kimo
    Griffiths, Elizabeth A.
    Zeidan, Amer M.
    Traer, Elie
    Saini, Lalit
    Amin, Harshad
    Mohan, Sanjay
    Lubbert, Michael
    Maness-Harris, Lori
    Foran, James
    Selleslag, Dominik
    Xicoy, Blanca
    Pollyea, Daniel A.
    Sallman, David A.
    Al-Kali, Aref
    Berdeja, Jesus G.
    Al-Ali, Haifa
    Zhu, Nancy Y.
    Lopez, Patricia Font
    Santillana, Guillermo Sanz
    Santini, Valeria
    Yimer, Habte
    Cripe, Larry D.
    Priego, Victor
    Odenike, Olatoyosi
    Heyrman, Bert
    Ferreiras, David Valcarcel
    Vachhni, Pankit J.
    Chan, Winny
    Sano, Yuri
    Mirakhur, Beloo
    Oganesian, Aram
    Keer, Harold
    Yacoub, Abdulraheem
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S376 - S377
  • [36] A phase I clinical trial of avelumab in combination with decitabine as first line treatment of unfit patients with acute myeloid leukemia
    Zheng, Hong
    Mineishi, Shin
    Claxton, David
    Zhu, Junjia
    Zhao, Chenchen
    Jia, Bei
    Ehmann, W. Christopher
    Rybka, Witold B.
    Naik, Seema
    Songdej, Natthapol
    Drabick, Joseph J.
    Hohl, Raymond J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (02) : E48 - E51
  • [37] Durable response with venetoclax in combination with decitabine or azacitadine in elderly patients with acute myeloid leukemia (AML).
    Dinardo, Courtney Denton
    Pratz, Keith William
    Potluri, Jalaja
    Pullarkat, Vinod A.
    Jonas, Brian Andrew
    Wei, Andrew H.
    Becker, Pamela Sue
    Frankfurt, Olga
    Xu, Tu
    Hong, Wan-Jen
    Chyla, Brenda
    Pollyea, Daniel Aaron
    Letai, Anthony G.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [38] Phase 2 study of chidamide in combination with CAG and venetoclax-azacitidine in older patients with newly diagnosed acute myeloid leukemia
    Liu, Qingyang
    Yang, Jingjing
    Lv, Lei
    Zhang, Xiawei
    Li, Meng
    Xu, Lingmin
    Huang, Sai
    Jing, Yu
    Dou, Liping
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [39] Durable Response with Venetoclax in Combination with Decitabine or Azacitidine in Elderly Patients with Acute Myeloid Leukemia (AML)
    DiNardo, Courtney D.
    Pratz, Keith
    Potluri, Jalaja
    Pullarkat, Vinod
    Jonas, Brian A.
    Wei, Andrew H.
    Becker, Pamela S.
    Frankfurt, Olga
    Xu, Tu
    Hong, Wan-Jen
    Chyla, Brenda
    Pollyea, Daniel A.
    Letai, Anthony
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S201 - S201
  • [40] Phase 2 study of epigenetic priming with decitabine followed by cytarabine for acute myeloid leukemia in older patients
    Im, Annie
    Quann, Kevin
    Agha, Mounzer
    Raptis, Anastasios
    Redner, Robert L.
    Hou, Jing-Zhou
    Farah, Rafic
    Dorritie, Kathleen A.
    Sehgal, Alison R.
    Normolle, Daniel
    Bovbjerg, Dana H.
    Aggarwal, Nidhi
    Herman, James
    Lontos, Konstantinos
    Boyiadzis, Michael
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (03) : 380 - 386
12345